- Home
- SSYS vs KROS Comparison
SSYS vs KROS Comparison
Compare SSYS & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSYS
- KROS
- Stock Information
- Founded
- SSYS 1989
- KROS 2015
- Country
- SSYS United States
- KROS United States
- Employees
- SSYS N/A
- KROS N/A
- Industry
- SSYS Computer peripheral equipment
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- SSYS Technology
- KROS Health Care
- Exchange
- SSYS Nasdaq
- KROS Nasdaq
- Market Cap
- SSYS 634.6M
- KROS 460.6M
- IPO Year
- SSYS 1994
- KROS 2020
- Fundamental
- Price
- SSYS $12.40
- KROS $11.12
- Analyst Decision
- SSYS Strong Buy
- KROS Buy
- Analyst Count
- SSYS 4
- KROS 11
- Target Price
- SSYS $11.50
- KROS $45.33
- AVG Volume (30 Days)
- SSYS 668.2K
- KROS 2.1M
- Earning Date
- SSYS 03-05-2025
- KROS 02-26-2025
- Dividend Yield
- SSYS N/A
- KROS N/A
- EPS Growth
- SSYS N/A
- KROS N/A
- EPS
- SSYS N/A
- KROS N/A
- Revenue
- SSYS $578,436,000.00
- KROS $651,000.00
- Revenue This Year
- SSYS N/A
- KROS $303.27
- Revenue Next Year
- SSYS $3.22
- KROS N/A
- P/E Ratio
- SSYS N/A
- KROS N/A
- Revenue Growth
- SSYS N/A
- KROS 8037.50
- 52 Week Low
- SSYS $6.05
- KROS $9.78
- 52 Week High
- SSYS $13.98
- KROS $73.00
- Technical
- Relative Strength Index (RSI)
- SSYS 76.57
- KROS 25.01
- Support Level
- SSYS $9.17
- KROS $11.04
- Resistance Level
- SSYS $9.91
- KROS $11.36
- Average True Range (ATR)
- SSYS 0.54
- KROS 0.53
- MACD
- SSYS 0.28
- KROS 1.15
- Stochastic Oscillator
- SSYS 98.44
- KROS 37.80
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.